203 related articles for article (PubMed ID: 23874502)
1. A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders.
Capece D; Zazzeroni F; Mancarelli MM; Verzella D; Fischietti M; Di Tommaso A; Maccarone R; Plebani S; Di Ianni M; Gulino A; Alesse E
PLoS One; 2013; 8(7):e68080. PubMed ID: 23874502
[TBL] [Abstract][Full Text] [Related]
2. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
[TBL] [Abstract][Full Text] [Related]
3. Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
Iacobucci I; Lonetti A; Cilloni D; Messa F; Ferrari A; Zuntini R; Ferrari S; Ottaviani E; Arruga F; Paolini S; Papayannidis C; Piccaluga PP; Soverini S; Saglio G; Pane F; Baruzzi A; Vignetti M; Berton G; Vitale A; Chiaretti S; Müschen M; Foà R; Baccarani M; Martinelli G
Haematologica; 2008 Dec; 93(12):1814-21. PubMed ID: 18838475
[TBL] [Abstract][Full Text] [Related]
4. Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia.
Bond J; Domaschenz R; Roman-Trufero M; Sabbattini P; Ferreiros-Vidal I; Gerrard G; Asnafi V; Macintyre E; Merkenschlager M; Dillon N
Oncotarget; 2016 Oct; 7(40):65923-65936. PubMed ID: 27588474
[TBL] [Abstract][Full Text] [Related]
5. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
Sun L; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Mao C; Vassilev A; Reaman GH; Uckun FM
Clin Cancer Res; 1999 Aug; 5(8):2112-20. PubMed ID: 10473095
[TBL] [Abstract][Full Text] [Related]
6. Alteration in Ikaros expression promotes B-1 cell differentiation into phagocytes.
Oliveira VC; Sodré ACP; Gomes CP; Moretti NS; Pesquero JB; Popi AF
Immunobiology; 2018 Feb; 223(2):252-257. PubMed ID: 29107383
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
[TBL] [Abstract][Full Text] [Related]
8. Relative expression of different Ikaros isoforms in childhood acute leukemia.
Meleshko AN; Movchan LV; Belevtsev MV; Savitskaja TV
Blood Cells Mol Dis; 2008; 41(3):278-83. PubMed ID: 18675565
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial effects of splice variants modulate function of Aiolos.
Caballero R; Setien F; Lopez-Serra L; Boix-Chornet M; Fraga MF; Ropero S; Megias D; Alaminos M; Sanchez-Tapia EM; Montoya MC; Esteller M; Gonzalez-Sarmiento R; Ballestar E
J Cell Sci; 2007 Aug; 120(Pt 15):2619-30. PubMed ID: 17646674
[TBL] [Abstract][Full Text] [Related]
10. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
Sun L; Heerema N; Crotty L; Wu X; Navara C; Vassilev A; Sensel M; Reaman GH; Uckun FM
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):680-5. PubMed ID: 9892693
[TBL] [Abstract][Full Text] [Related]
11. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia.
Nakase K; Ishimaru F; Avitahl N; Dansako H; Matsuo K; Fujii K; Sezaki N; Nakayama H; Yano T; Fukuda S; Imajoh K; Takeuchi M; Miyata A; Hara M; Yasukawa M; Takahashi I; Taguchi H; Matsue K; Nakao S; Niho Y; Takenaka K; Shinagawa K; Ikeda K; Niiya K; Harada M
Cancer Res; 2000 Aug; 60(15):4062-5. PubMed ID: 10945610
[TBL] [Abstract][Full Text] [Related]
12. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
[TBL] [Abstract][Full Text] [Related]
13. Multiple functions of Ikaros in hematological malignancies, solid tumor and autoimmune diseases.
Chen Q; Shi Y; Chen Y; Ji T; Li Y; Yu L
Gene; 2019 Feb; 684():47-52. PubMed ID: 30352248
[TBL] [Abstract][Full Text] [Related]
14. Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiation.
Tonnelle C; Dijon M; Moreau T; Garulli C; Bardin F; Chabannon C
Mol Immunol; 2009 May; 46(8-9):1736-43. PubMed ID: 19285729
[TBL] [Abstract][Full Text] [Related]
15. Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase.
Ma H; Qazi S; Ozer Z; Zhang J; Ishkhanian R; Uckun FM
PLoS One; 2013; 8(8):e71302. PubMed ID: 23977012
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of Ikaros expression in B-1 cells: New insights in the malignant transformation to chronic lymphocytic leukemia.
Oliveira VC; Lacerda MP; Moraes BBM; Gomes CP; Maricato JT; Souza OF; Schenkman S; Pesquero JB; Moretti NS; Rodrigues CA; Popi AF
J Leukoc Biol; 2019 Sep; 106(3):581-594. PubMed ID: 31299112
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development.
Sun L; Liu A; Georgopoulos K
EMBO J; 1996 Oct; 15(19):5358-69. PubMed ID: 8895580
[TBL] [Abstract][Full Text] [Related]
18. Regulation of L-selectin expression by a dominant negative Ikaros protein.
Christopherson I; Piechoki M; Liu G; Ratner S; Galy A
J Leukoc Biol; 2001 Apr; 69(4):675-83. PubMed ID: 11310856
[TBL] [Abstract][Full Text] [Related]
19. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins.
Molnár A; Georgopoulos K
Mol Cell Biol; 1994 Dec; 14(12):8292-303. PubMed ID: 7969165
[TBL] [Abstract][Full Text] [Related]
20. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.
Iacobucci I; Lonetti A; Messa F; Cilloni D; Arruga F; Ottaviani E; Paolini S; Papayannidis C; Piccaluga PP; Giannoulia P; Soverini S; Amabile M; Poerio A; Saglio G; Pane F; Berton G; Baruzzi A; Vitale A; Chiaretti S; Perini G; Foà R; Baccarani M; Martinelli G
Blood; 2008 Nov; 112(9):3847-55. PubMed ID: 18650450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
